Evidence map›Paper›PMID 27630827›Full record

ArticleFrontiers in cellular and infection microbiology2016

Unique Footprint in the scl1.3 Locus Affects Adhesion and Biofilm Formation of the Invasive M3-Type Group A Streptococcus.

Beth A Bachert, Soo J Choi, Paul R LaSala, Tiffany I Harper, Dudley H McNitt, Dylan T Boehm, Clayton C Caswell, Pawel Ciborowski, Douglas R Keene, Anthony R Flores and 5 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Regulation of erm(T) MLSnpj antimicrobials and resistance · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Beth A BachertDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University Morgantown, WV, USA.
Soo J ChoiDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University Morgantown, WV, USA.
Paul R LaSalaDepartment of Pathology, West Virginia University Morgantown, WV, USA.
Tiffany I HarperDepartment of Pathology, West Virginia University Morgantown, WV, USA.
Dudley H McNittDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University Morgantown, WV, USA.
Dylan T BoehmDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University Morgantown, WV, USA.
Clayton C CaswellDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University Morgantown, WV, USA.
Pawel CiborowskiDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center Omaha, NE, USA.
Douglas R KeeneShriners Hospital for Children Portland, OR, USA.
Anthony R FloresSection of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Texas Children's HospitalHouston, TX, USA; Department of Pathology and Genomic Medicine, Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute and Hospital SystemHouston, TX, USA.
James M MusserDepartment of Pathology and Genomic Medicine, Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute and Hospital System Houston, TX, USA.
Flavia SquegliaInstitute of Biostructures and Bioimaging, National Research Council Naples, Italy.
Daniela MarascoDepartment of Pharmacy, University of Naples Frederico II Naples, Italy.
Rita BerisioInstitute of Biostructures and Bioimaging, National Research Council Naples, Italy.
Slawomir LukomskiDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University Morgantown, WV, USA.

Funding

WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
THE ROLE OF HEF1 PROTEIN IN INVASION OF METASTATIC BREAST CANCERP20RR016440 · NCRR · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2001 to 2010
$22.8M
West Virginia Flow Cytometry Core FacilityP30GM103488 · NIGMS · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2012 to 2016
$4.8M
Nebraska Center for VirologyP30GM103509 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2012 to 2014
$3.3M
Sc1 Proteins of S pyogenes: Biology and FunctionR01AI050666 · NIAID · WEST VIRGINIA UNIVERSITY · PI LUKOMSKI, SLAWOMIR · 2002 to 2005
$1.0M
BECTON-DICKINSON FACSARIA FLOW CYTOMETER: SARCOPENIAS10RR020866 · NCRR · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2006 to 2006
$425k
Scl1-mediated immune evasion of the rheumatologenic group A StreptococcusR21AI083683 · NIAID · WEST VIRGINIA UNIVERSITY · PI LUKOMSKI, SLAWOMIR · 2010 to 2011
$404k
Special Becton Dickinson Fortessa Flow CytometerS10OD016165 · OD · WEST VIRGINIA UNIVERSITY · PI CUFF, CHRISTOPHER F · 2013 to 2013
$384k
NCRR NIH HHS P20 RR016440NCRR NIH HHS S10 RR020866NIAID NIH HHS R01 AI050666NIAID NIH HHS R21 AI083683NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P30 GM103488NIGMS NIH HHS P30 GM103509NIH HHS S10 OD016165
6 · The paper itself

Abstract

The streptococcal collagen-like proteins 1 and 2 (Scl1 and Scl2) are major surface adhesins that are ubiquitous among group A Streptococcus (GAS). Invasive M3-type strains, however, have evolved two unique conserved features in the scl1 locus: (i) an IS1548 element insertion in the scl1 promoter region and (ii) a nonsense mutation within the scl1 coding sequence. The scl1 transcript is drastically reduced in M3-type GAS, contrasting with a high transcription level of scl1 allele in invasive M1-type GAS. This leads to a lack of Scl1 expression in M3 strains. In contrast, while scl2 transcription and Scl2 production are elevated in M3 strains, M1 GAS lack Scl2 surface expression. M3-type strains were shown to have reduced biofilm formation on inanimate surfaces coated with cellular fibronectin and laminin, and in human skin equivalents. Repair of the nonsense mutation and restoration of Scl1 expression on M3-GAS cells, restores biofilm formation on cellular fibronectin and laminin coatings. Inactivation of scl1 in biofilm-capable M28 and M41 strains results in larger skin lesions in a mouse model, indicating that lack of Scl1 adhesin promotes bacterial spread over localized infection. These studies suggest the uniquely evolved scl1 locus in the M3-type strains, which prevents surface expression of the major Scl1 adhesin, contributed to the emergence of the invasive M3-type strains. Furthermore these studies provide insight into the molecular mechanisms mediating colonization, biofilm formation, and pathogenesis of group A streptococci.

Indexed as

Bacterial AdhesionGenetic LociAnimalsAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsBiofilmsCarrier ProteinsCollagenDisease Models, AnimalGenetic Complementation TestHumansMiceSerogroupStreptococcal InfectionsStreptococcus pyogenesAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsCarrier ProteinsCollagenScl1 protein, Streptococcusstreptococcal M proteinbiofilmcolonizationECMM3-type streptococciScl1Scl2Streptococcus pyogenes

Identifiers

PMID27630827
PMCPMC5005324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.